Grant recipient
The Walter and Eliza Hall Institute of Medical Research
Also an AusTender supplier: THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH, with 3 contracts worth $1.1m over their whole life. matched by name
$329m
whole-of-term value of 140 grant awards published 2022-07-04 to 2026-09-14
$64m falls in 2026-27, from 122 active awards. estimate: annualised
Award values as published on GrantConnect, each over the grant’s whole term. GrantConnect publishes no ABN, so awards are grouped by name: spellings that differ only in case, punctuation or a company suffix count as one recipient. How recipients are grouped
By agency
| Granting agency | Awards | Total value |
|---|---|---|
| National Health and Medical Research Council (NHMRC) | 118 | $250m |
| Department of Health, Disability and Ageing | 8 | $42m |
| Department of Health and Aged Care | 10 | $36m |
| Cancer Australia | 2 | $1.2m |
| Department of Foreign Affairs and Trade | 2 | $365k |
Awards
Largest first.
| Activity | Agency | Category | Round | Published | Term | Value |
|---|---|---|---|---|---|---|
| Bridging Barriers in Brain Cancer GA544914 as “THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH” |
Department of Health, Disability and Ageing | Health and Medical Research | GO5855 | 2026-03-16 | 2026-03-06 to 2031-11-07 | $21m |
| Next-generation dendritic cell immunotherapy for intractable solid can… GA449702 as “THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH” |
Department of Health and Aged Care | Health and Medical Research | GO5855 | 2025-04-02 | 2025-03-28 to 2030-10-30 | $19m |
| 2025 Independent Research Institutes Infrastructure Support Scheme GA545744 |
National Health and Medical Research Council (NHMRC) | Health and Medical Research | GO7848 | 2026-03-30 | 2025-11-01 to 2027-10-31 | $11m |
| 2024 Independent Research Institutes Infrastructure Support Scheme GA407024 |
National Health and Medical Research Council (NHMRC) | Health and Medical Research | GO7111 | 2024-11-25 | 2024-11-01 to 2025-12-31 | $7.8m |
| Accessible High-Throughput and Virtual Screening for Australian Resear… GA562838 as “THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH” |
Department of Health, Disability and Ageing | Health and Medical Research | GO7080 | 2026-06-03 | 2026-06-02 to 2029-12-31 | $7.7m |
| 2022 Independent Research Institutes Infrastructure Support Scheme GA294873 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5711 | 2023-04-12 | 2022-11-01 to 2023-12-31 | $7.6m |
| 2023 Independent Research Institutes Infrastructure Support Scheme GA342632 |
National Health and Medical Research Council (NHMRC) | Health and Medical Research | GO6368 | 2023-11-06 | 2023-11-01 to 2025-10-31 | $7.6m |
| A mechanistic approach to next-generation vaccine design GA398483-V3 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6782 | 2024-10-08 | 2025-01-01 to 2029-12-31 | $5.8m |
| Identifying and overcoming mechanisms of immune evasion in cancer GA398485-V3 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6782 | 2024-10-08 | 2025-01-01 to 2029-12-31 | $5.8m |
| Developing a vaccine against Plasmodium, blood, liver and transmission… GA520865-V1 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7526 | 2025-12-08 | 2026-01-01 to 2030-12-31 | $5.6m |
| Targeting neuronal vulnerabilities to treat Parkinson's disease GA520893-V1 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7526 | 2025-12-08 | 2026-01-01 to 2030-12-31 | $5.6m |
| CAVIAT-R: Chemotherapy and Venetoclax in AML Therapy- Randomised GA441922-V1 |
Department of Health and Aged Care | Medical Research | GO6540 | 2025-03-17 | 2025-04-01 to 2030-12-31 | $5.4m |
| A universal “correct and select†gene therapy platform to cure mon… GA544568 |
Department of Health, Disability and Ageing | Medical Research | GO7561 | 2026-03-10 | 2026-04-01 to 2031-03-31 | $5.3m |
| “GLIMMER†- Glioma Liquid biopsy and Multiomic-Monitoring Enabled… GA271254 |
Department of Health and Aged Care | Medical Research | GO5328 | 2022-10-31 | 2022-11-01 to 2027-10-31 | $5.0m |
| CIRCULATING TUMOUR DNA INFORMED MANAGEMENT OF EARLY-STAGE COLORECTAL C… GA271290-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $4.1m |
| Building best-in-class bioinformatics tools to drive next generation b… GA271280 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $3.6m |
| Exploiting breast stem cell research discoveries for transfer to the c… GA352292-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2025-01-01 to 2029-12-31 | $3.5m |
| Statistical bioinformatics for medical research GA352315-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2024-01-01 to 2028-12-31 | $3.4m |
| Cell death and inflammation GA396164-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-09-16 | 2026-01-01 to 2030-12-31 | $3.4m |
| Malaria and development of new antimalarials GA396165-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-09-16 | 2026-01-01 to 2030-12-31 | $3.4m |
| Deciphering mechanisms underlying breast cancer to improve patient out… GA396180-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-09-16 | 2026-01-01 to 2030-12-31 | $3.4m |
| Leveraging population cohorts to link common and rare genetic disease… GA387375-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-07-22 | 2026-01-01 to 2030-12-31 | $3.4m |
| Harnessing multi-omics for precise cancer insights GA352243-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2024-01-01 to 2028-12-31 | $3.4m |
| Early intervention for therapeutic benefit in AML: a national program… GA273519 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-11-21 | 2023-01-01 to 2027-12-31 | $3.3m |
| Understanding the molecular basis of therapy resistance to improve out… GA396177-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-09-16 | 2025-01-01 to 2029-12-31 | $3.3m |
| Killing zombies: the emergence of dead enzymes as therapeutic targets… GA396185-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-09-16 | 2025-01-01 to 2029-12-31 | $3.3m |
| Mapping and mining the ubiquitin system GA387370-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-07-22 | 2025-01-01 to 2029-12-31 | $3.3m |
| Investigating programmed cell death and the tumour suppressor p53 to d… GA516444 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2027-01-01 to 2031-12-31 | $3.3m |
| Exploring Cell Death Signaling for Drug Target Discovery GA516445 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2027-01-01 to 2031-12-31 | $3.3m |
| Unravelling the Diversity and Function of Tissue-Resident Lymphocytes GA396182-V3 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-09-16 | 2025-01-01 to 2029-12-31 | $3.3m |
| CRE for Parkinson’s Disease: Advancing Precision Medicine GA495828 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7245 | 2025-08-04 | 2025-11-01 to 2030-10-31 | $3.3m |
| CRE in Acute Myeloid Leukaemia GA495829 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7245 | 2025-08-04 | 2025-11-01 to 2030-10-31 | $3.3m |
| ADAPT (Achieving Durable remission via Adaptive Pro-survival Targeting… GA289079-V1 |
Department of Health, Disability and Ageing | Medical Research | GO5344 | 2023-03-20 | 2023-02-01 to 2028-12-31 | $3.3m |
| Dissecting how age and mutations shape haematopoietic clonal pathways… GA579504 as “Walter and Eliza Hall Institute of Medical Research” |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7711 | 2026-09-14 | 2027-01-01 to 2031-12-31 | $3.3m |
| Leveraging T cell interactions for next-generation vaccination and imm… GA579537 as “Walter and Eliza Hall Institute of Medical Research” |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7711 | 2026-09-14 | 2027-01-01 to 2031-12-31 | $3.3m |
| Innovations in anaemia research: from trials to translation GA516437 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2027-01-01 to 2031-12-31 | $3.3m |
| Long-lived remodelling of epigenetic state to treat disease GA516439 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2026-01-01 to 2030-12-31 | $3.3m |
| Understanding acute gluten immunity to improve coeliac disease diagnos… GA352218-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2025-01-01 to 2029-12-31 | $3.2m |
| Harnessing the humoral immune system to treat disease GA352287-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2024-01-01 to 2028-12-31 | $3.2m |
| A precision medicine approach to the development of innovative Immunot… GA387390-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-07-22 | 2025-01-01 to 2029-12-31 | $3.2m |
| Enhancing the activity of BH3 mimetic drugs in blood cancers GA400038-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-10-21 | 2025-01-01 to 2029-12-31 | $2.9m |
| Glioblastoma Immunotherapy Advancement with Nivolumab and Relatlimab GA474832-V1 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7022 | 2025-06-03 | 2025-07-01 to 2029-10-30 | $2.7m |
| Targeting Glycosylation in Myeloproliferative Diseases GA389261 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-08-19 | 2025-01-01 to 2029-12-31 | $2.6m |
| Drug Discovery and Chemical Biology of cell Death processes: Novel Ins… GA271324 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $2.6m |
| P. vivax Serological Testing & Treatment: a novel intervention to faci… GA271308 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $2.5m |
| Using advanced CRISPR tools to improve clinical therapies for poor pro… GA273522 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-11-21 | 2023-01-01 to 2027-12-31 | $2.4m |
| Antibody-based therapies against infectious diseases GA271297 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $2.3m |
| Understanding the drivers of early onset pancreatic cancer in Australi… GA559911 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7773 | 2026-05-11 | 2026-05-01 to 2029-04-30 | $2.2m |
| Optimising CAR-T cell immunotherapy through targeted modulation of sig… GA352049 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6133 | 2024-01-08 | 2024-01-01 to 2028-12-31 | $2.2m |
| Improving CAR T-cell immunotherapies through balanced CD4/CD8 signalli… GA409771 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6844 | 2024-12-23 | 2025-01-01 to 2029-12-31 | $2.1m |
| Long-acting antimalarials for malaria chemovaccination GA409891 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6844 | 2024-12-23 | 2025-01-01 to 2028-12-31 | $2.0m |
| Targeting a previously unrecognised cellular stress-sensing node for t… GA521994 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-01-01 to 2028-12-31 | $1.8m |
| Uncovering the molecular determinants driving metastasis in small cell… GA520883 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-08 | 2026-01-01 to 2029-12-31 | $1.8m |
| Overcoming tumour immunosuppression in next generation dendritic cell… GA522040 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-01-01 to 2029-12-31 | $1.8m |
| Decoding the Mechanisms of Signal Propagation through the Wnt Signalin… GA516436 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2026-01-01 to 2030-12-31 | $1.8m |
| Using the 3D genome to predict and treat leukaemia GA516438 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2026-01-01 to 2030-12-31 | $1.8m |
| Investigating post-transcriptional control of T cell immunity against… GA516442 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2026-01-01 to 2030-12-31 | $1.8m |
| Boosting the efficacy of BH3-mimetic drugs for p53-deficient blood can… GA516443 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7020 | 2025-11-10 | 2026-01-01 to 2030-12-31 | $1.8m |
| Investigating macrophage programming during dead cell clearance GA400051-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-10-21 | 2025-09-01 to 2030-08-31 | $1.8m |
| Proteotoxic stress, Protein Kinase R and human disease GA353574 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-22 | 2024-06-01 to 2029-05-31 | $1.8m |
| Exploiting malarial invasion proteins for novel multi-stage malaria va… GA352297 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2025-01-01 to 2029-12-31 | $1.7m |
| Statistical methods for advancing cutting edge single cell and spatial… GA352316 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2025-01-01 to 2029-12-31 | $1.7m |
| Capturing atomic snapshots to visualise epigenetic silencing machinery… GA271301 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $1.7m |
| Pioneering data analysis methods to decrypt the cancer transcriptome GA271319 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $1.7m |
| Gene regulatory mechanisms by autoimmune risk loci in primary human ce… GA279576 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5477 | 2023-01-23 | 2023-01-01 to 2026-12-31 | $1.7m |
| Molecular Basis of Toxoplasma’s Interaction with the Brain GA409754 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6844 | 2024-12-23 | 2025-01-01 to 2029-12-31 | $1.7m |
| SMART: Streamlining GlioblastoMA Radiation Therapy GA474308-V1 as “THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH” |
Department of Health, Disability and Ageing | Health and Medical Research | GO6578 | 2025-05-20 | 2026-01-12 to 2030-12-31 | $1.6m |
| Time of Administration of Immunotherapy Leading to Optimal Results -TA… GA563926 as “THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH” |
Department of Health, Disability and Ageing | Health and Medical Research | GO7381 | 2026-06-09 | 2026-06-03 to 2031-12-15 | $1.6m |
| Novel biomarkers for improved diagnosis and management of iron deficie… GA531210 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7567 | 2026-01-19 | 2026-01-01 to 2028-12-31 | $1.6m |
| Using advanced structural biology to exploit BCL2 effector proteins fo… GA271299 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $1.6m |
| RBR E3 ubiquitin ligases in health and disease GA271339 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5390 | 2022-10-31 | 2023-01-01 to 2027-12-31 | $1.6m |
| Development of aspartyl protease inhibitors targeting the diarrheal pa… GA351948 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6209 | 2024-01-08 | 2024-01-01 to 2026-12-31 | $1.6m |
| Selective Targeting of Tissue-resident Tregs in Gastrointestinal Disea… GA352103 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6133 | 2024-01-08 | 2024-01-01 to 2027-12-31 | $1.6m |
| Defining plasticity of human T cell exhaustion by leveraging gluten ch… GA521979 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-01-01 to 2029-12-31 | $1.6m |
| Longitudinal analysis of glioma: identifying new biomarkers of treatme… GA389250 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6477 | 2024-08-19 | 2025-01-01 to 2029-12-31 | $1.6m |
| Mechanisms underlying the pathology of spliceosomal mutations in myelo… GA409749-V1 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6844 | 2024-12-23 | 2025-01-01 to 2028-12-31 | $1.5m |
| Identification of effective therapeutic targets for β-catenin activat… GA409763 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6844 | 2024-12-23 | 2025-01-01 to 2028-12-31 | $1.5m |
| Elucidating the signalling functions of Transmembrane Pseudokinases as… GA279555 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5477 | 2023-01-23 | 2023-01-01 to 2026-12-31 | $1.5m |
| Reversing defects in thymic stroma to restore immune function GA352006 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6133 | 2024-01-08 | 2024-01-01 to 2027-12-31 | $1.5m |
| Optimizing the Potential of BH3 Mimetics in B Cell Malignancy GA352329 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6014 | 2024-01-08 | 2025-01-01 to 2029-12-31 | $1.4m |
| Molecular function of the chromatin reader SP140 in human B cells and… GA352122 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6133 | 2024-01-08 | 2024-01-01 to 2027-12-31 | $1.4m |
| Uncovering the interactions between tissue-resident plasma cells and t… GA409809 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6844 | 2024-12-23 | 2025-01-01 to 2028-12-31 | $1.4m |
| Activating PINK1-mediated damage signalling to enhance mitochondrial c… GA521981 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-01-01 to 2028-12-31 | $1.4m |
| CELECT: precision gene editing for positive selection of therapeutic c… GA520853 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-08 | 2026-01-01 to 2028-12-31 | $1.3m |
| Molecular impact of climate change upon respiratory health GA521991 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-10-01 to 2029-09-30 | $1.2m |
| Antibody based therapeutic development for coronaviruses GA276505 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5477 | 2022-12-19 | 2023-01-01 to 2026-12-31 | $1.2m |
| A new approach to preventing haemolytic disease of the foetus and newb… GA522016 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-01-01 to 2028-12-31 | $1.2m |
| Glycosylation as a new target in myelofibrosis GA352192 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6133 | 2024-01-08 | 2024-01-01 to 2026-12-31 | $1.2m |
| Unravelling the Dynamic Crosstalk Between Malignant Haematopoiesis and… GA521983 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-04-01 to 2029-03-31 | $1.2m |
| Development of a new drug for Crohn's Disease GA351952-V1 as “Walter and Eliza Hall Institute of Medical Research” |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6209 | 2024-01-08 | 2024-01-01 to 2027-12-31 | $1.2m |
| A lethal and irresistible combination: Simultaneous targeting of the S… GA268497 |
Department of Health and Aged Care | Medical Research | GO5208 | 2022-10-04 | 2022-06-19 to 2024-05-31 | $1.1m |
| Defining IL-6 family cytokine signalling to identify better treatment… GA520943 |
Department of Health, Disability and Ageing | Medical Research | GO7225 | 2025-12-08 | 2025-12-01 to 2027-11-30 | $1.1m |
| Short-circuiting a cell death rheostat to boost BCL2 inhibitor efficac… GA409840 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6844 | 2024-12-23 | 2025-01-01 to 2027-12-31 | $1.1m |
| mRNA processing in development and disease GA352101-V2 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6133 | 2024-01-08 | 2024-01-01 to 2027-12-31 | $1.1m |
| Clearing the Fog: Defining the molecular mechanism of neurological PAS… GA383287 |
Department of Health and Aged Care | Medical Research | GO6419 | 2024-06-24 | 2024-06-01 to 2026-05-31 | $1.1m |
| Development of a Plasmodium vivax multi-analyte lateral flow assay to… GA276483 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO5590 | 2022-12-19 | 2023-01-01 to 2025-12-31 | $1.0m |
| A novel stem cell-derived manufacturing platform for next-generation d… GA288997 |
Department of Health and Aged Care | Medical Research | GO5567 | 2023-03-20 | 2023-02-01 to 2025-05-31 | $1.0m |
| Restraining mitochondrial damage-induced inflammation in Parkinson's D… GA351970 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO6133 | 2024-01-08 | 2024-01-01 to 2026-12-31 | $971k |
| A CCTV analog recorder for mouse embryogenesis GA522024 |
National Health and Medical Research Council (NHMRC) | Medical Research | GO7599 | 2025-12-15 | 2026-01-01 to 2028-12-31 | $949k |
| Development of a patient stem-cell derived disease model platform for… GA441937-V1 |
Department of Health and Aged Care | Medical Research | GO6774 | 2025-03-17 | 2025-04-01 to 2028-03-31 | $927k |
Showing 1–100 of 140. Page 1 of 2 Next → Download all 140 as CSV
These records are as published by the agencies on GrantConnect, where each award can be found by its ID. If something here is wrong, the agency that published the award can correct it, and we will pick up the correction at the next load. Report a problem with this page.